Quantcast
Last updated on April 18, 2014 at 16:58 EDT

Latest Opioid Stories

2013-10-29 08:32:28

Study Demonstrates High Statistical Significance in Both Primary Endpoints of Reduction of Opioid-Induced Nausea/Vomiting and Pain JUPITER, Fla., Oct. 29, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products, announced today that it has completed its Phase 3 clinical trial of CL-108 at the midway point. (CL-108 is a strong pain-reliever designed to also prevent nausea and...

2013-10-28 08:28:59

Signature Support(TM) Program offers a full-range of services to simplify coverage support and patient assistance for patients taking Lazanda NEWARK, Calif., Oct. 28, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it has launched Lazanda® (fentanyl) nasal spray with its newly formed dedicated team of regional sales specialists and the new Signature(TM) Support Program. Lazanda is indicated for the management of breakthrough pain in cancer patients (BTPc) 18 years of...

2013-10-24 08:34:29

MELBOURNE, Australia, Oct. 24, 2013 /PRNewswire/ -- -- Oxymorphone patch achieves world first therapeutic plasma concentrations in all subjects in clinical trial -- Results from Phase 1 oxymorphone patch clinical trial demonstrates excellent drug delivery profile -- Most commercially significant trial result ever achieved by Phosphagenics as it proves the concept for an estimated $1 billion annual sales -- Phase 2 study to proceed focusing...

2013-10-18 12:05:28

Death from analgesic overdose, including the painkillers oxycodone and codeine, is more concentrated in economically disadvantaged neighborhoods with a prevalence of high divorce, single-parent homes than deaths from unintentional causes, according to research conducted at Columbia University's Mailman School of Public Health. Yet, compared to heroin overdose deaths, analgesic overdoses were found to occur in higher-income neighborhoods. This study is among the first to provide a framework...

2013-10-15 08:31:22

KING OF PRUSSIA, Pa., Oct. 15, 2013 /PRNewswire/ -- Trevena, Inc. (Trevena), a clinical stage pharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the electronic publication of the first clinical manuscript of its lead CNS asset, TRV130. The manuscript entitled, "First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers." can be viewed online at the Journal of Clinical...

2013-10-14 23:02:04

The law firm of Heygood, Orr & Pearson is announcing the launch of its new fentanyl pain patch website, Fentanyl Patch Lawsuits (http://fentanylpatchlawsuits.com/). The site will serve as a news and information resource for patients and their families whose lives have been affected by fentanyl prescriptions. Dallas, Texas (PRWEB) October 14, 2013 The law firm of Heygood, Orr & Pearson is announcing the launch of its new fentanyl pain patch website, Fentanyl Patch Lawsuits...

Opioids In The Brain Ease Social Pain
2013-10-11 04:48:35

Brett Smith for redOrbit.com - Your Universe Online While previous research has shown that our brains release pain-killing opioids when the body experiences physical harm, a new study in the journal Molecular Psychiatry has revealed that this system is also activated by social pain. The study researchers also discovered that those who score high on a personality attribute called resilience, or the capacity to cope with environmental change, showed the highest level of natural painkiller...

2013-10-09 12:25:48

JUPITER, Fla., Oct. 9, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the commencement of a research program to evaluate anti-emetic effects on opioid-induced hyperalgesia and physical dependence with the Anesthesiology, Pain and...

2013-10-08 11:47:46

New pain management approaches range from a readily available bedside treatment to an experimental prolonged drug delivery system New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons. One pain treatment utilized the simple but nonstandard application of ice packs after major abdominal operations in patients, and the other...

2013-10-07 20:22:26

Two new studies reveal methods to identify and reduce controlled substances and opioid abuse and misuse ST. PAUL, Minn., Oct. 7, 2013 /PRNewswire/ -- The misuse and abuse of controlled prescription drugs, such as opioid pain medications, is a serious public health issue. Strategies to identify and intervene with high-risk users can help reduce potential abuse and misuse of the drugs, according to two new studies by pharmacy benefit manager Prime Therapeutics LLC (Prime). Prime is...